Close

Teva Pharma (TEVA) Announces U.S. Launch of QVAR RediHaler Inhalation Aerosol

February 16, 2018 11:40 AM EST Send to a Friend
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol is now ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login